Inventor · disambiguated record
Tetsuya Nagata
Also filed as: NAGATA TETSUYA
23 granted patents·21 pending applications·403 citations·filing 2011–2025
97Inventor score
Files withNIPPON SHINYAKU CO LTD29UNIV NAT CORP TOKYO MEDICAL & DENTAL13TAKEDA PHARMACEUTICALS CO1WATANABE NAOKI1
Top patents by PatentIndex Score
44 records- 0198US11028122B1Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2021·Granted Jun 8, 2021·14 cites·5 claims
- 0298US10662217B2Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2019·Granted May 26, 2020·15 cites·4 claims
- 0398US10487106B2Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2019·Granted Nov 26, 2019·33 cites·2 claims
- 0498US10407461B2Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2019·Granted Sep 10, 2019·33 cites·2 claims
- 0598US10385092B2Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2019·Granted Aug 20, 2019·39 cites·3 claims
- 0698US10329319B2Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2017·Granted Jun 25, 2019·14 cites·7 claims
- 0798US9708361B2Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2015·Granted Jul 18, 2017·38 cites·7 claims
- 0898US9079934B2Antisense nucleic acidsWATANABE NAOKI·Filed 2011·Granted Jul 14, 2015·53 cites·7 claims
- 0997US9840706B2Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2015·Granted Dec 12, 2017·41 cites·12 claims
- 1096US10781448B2Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2018·Granted Sep 22, 2020·14 cites·13 claims
- 1196US9988629B2Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2015·Granted Jun 5, 2018·39 cites·10 claims
- 1296US9512424B2Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2012·Granted Dec 6, 2016·37 cites·9 claims
- 1395US10683322B2Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2019·Granted Jun 16, 2020·4 cites·10 claims
- 1495US9890381B2Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2016·Granted Feb 13, 2018·15 cites·9 claims
- 1594US10870676B2Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2019·Granted Dec 22, 2020·3 cites·18 claims
- 1693US2025042933A1Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2024·Application pending·0 cites
- 1792US10647741B2Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2019·Granted May 12, 2020·2 cites·12 claims
- 1890US11053497B2Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2019·Granted Jul 6, 2021·3 cites·9 claims
- 1989US2025188459A1Antisense Nucleic AcidsNIPPON SHINYAKU CO LTD·Filed 2024·Application pending·0 cites
- 2088US11433089B2Blood-brain barrier permeable heteroduplex nucleic acidUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2017·Granted Sep 6, 2022·3 cites·12 claims
- 2188US11193125B2Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2017·Granted Dec 7, 2021·3 cites·18 claims
- 2288US2025145997A1Antisense Nucleic AcidsNIPPON SHINYAKU CO LTD·Filed 2024·Application pending·0 cites
- 2387US2023151050A1Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2022·Application pending·0 cites
- 2482US2025084412A1Antisense Nucleic AcidsNIPPON SHINYAKU CO LTD·Filed 2024·Application pending·0 cites
- 2581US2021340171A1Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2021·Application pending·0 cites
- 2680US2021284680A1Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2021·Application pending·0 cites
- 2779US2021179659A1Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2020·Application pending·0 cites
- 2876US12060556B2Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2021·Granted Aug 13, 2024·0 cites·13 claims
- 2974US2022162604A1Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2021·Application pending·0 cites
- 3072US2021222169A1Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2020·Application pending·0 cites
- 3169US2023024153A1Blood-brain barrier permeable heteroduplex nucleic acidUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2022·Application pending·0 cites
- 3269US2023295628A1Nucleic acid complexUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2023·Application pending·0 cites
- 3365US11597928B2Nucleic acid complexUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2019·Granted Mar 7, 2023·0 cites·20 claims
- 3464US11851654B2Nucleic acid with reduced toxicityUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2019·Granted Dec 26, 2023·0 cites·15 claims
- 3564US2025339459A1Modified heteronucleic acid containing morpholino nucleic acidUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2022·Application pending·0 cites
- 3662US2024240183A1Heteronucleic acid containing scpBNA or AmNAUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2022·Application pending·0 cites
- 3761US2024390508A1Human transferrin receptor binding peptide-drug conjugateTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 3860US12305169B2BBB-crossing lipid ligand of hetero nucleic acidUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2019·Granted May 20, 2025·0 cites·28 claims
- 3960US2018179538A1Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2018·Application pending·0 cites
- 4055US2023174981A1Heteronucleic acid containing morpholino nucleic acidUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2021·Application pending·0 cites
- 4154US2024117346A1Modified hetero nucleic acidsUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2020·Application pending·0 cites
- 4253US2022135972A1Optimal ps modification pattern for heteronucleic acidsUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2020·Application pending·0 cites
- 4352US2025333736A1Bbb-crossing lipid ligand of hetero nucleic acidUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2025·Application pending·0 cites
- 4449US2022175817A1Pharmaceutical Composition for Treating Muscle DiseaseUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tetsuya Nagata files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →